• BGJ398 Workflow for FGFR Signaling Research

  2026-08-22

  BGJ398 (NVP-BGJ398) combines strong FGFR1/2/3 activity with useful kinase selectivity for oncology research and pathway studies. This practical guide connects cancer-cell assays with a carefully qualified developmental-biology application inspired by comparative guinea pig and mouse data.

• SIRT1, Mitochondrial Biogenesis, and Prion Toxicity

  2026-08-22

  Zhao and colleagues identify a SIRT1–PGC-1α–TFAM axis that links mitochondrial biogenesis with neuronal injury caused by the prion peptide PrP106–126 in N2a cells. Their findings position SIRT1 activation, including resveratrol treatment, as a mechanistically testable strategy for restoring mitochondrial function and limiting apoptosis in a cellular prion model.

• L1023 Anti-Cancer Compound Library Workflow

  2026-08-21

  Turn a 1,164-compound oncology collection into a decision-ready workflow for phenotypic screening, resistance biology, and mechanism validation. This guide connects MCL1-focused apoptosis assays with broader pathway profiling, including BRAF and mTOR-oriented screens, while emphasizing plate quality, orthogonal confirmation, and practical troubleshooting.

• Hexa-Acylated LPS and Cancer Immunotherapy Response

  2026-08-20

  This Nature Microbiology study moves beyond taxonomic descriptions of the gut microbiome by identifying the acylation state of microbial lipopolysaccharide as a functional determinant of anti-PD-1 response. Human metagenomic analysis, immune assays, and mouse tumor experiments show that hexa-acylated LPS can enhance TLR4-dependent antitumor immunity, whereas hypo-acylated LPS may oppose it.

• KX2-391 dihydrochloride: Assay Guide

  2026-08-20

  A scenario-based guide to using KX2-391 dihydrochloride in cell viability, proliferation, cytotoxicity, HBV, and BoNT/A workflows. It explains how SKU A3535 supports concentration selection, solvent control, mechanism-aware interpretation, and practical product evaluation.

• Fluorescein TSA Fluorescence System Kit Workflow

  2026-08-19

  Learn how to apply tyramide-based fluorescence amplification to low-abundance targets in IHC, ICC, and ISH. This workflow connects the kit’s spatially retained signal to metastatic HNSCC research while providing practical setup, optimization, and troubleshooting guidance.

• Nelfinavir Mesylate: Applied Research Workflows

  2026-08-19

  Nelfinavir Mesylate supports both cell-based HIV-1 protease inhibition assays and mechanistic studies of DDI2–NFE2L1 control of ferroptosis. This guide translates its biochemical potency, formulation properties, and cross-domain use into practical workflows, controls, and troubleshooting decisions.

• Paroxetine Mesylate: Applied Research Workflows

  2026-08-18

  Paroxetine Mesylate supports a practical research strategy spanning SERT pharmacology, enzyme-interaction studies, kinase profiling, and colorectal cancer models. This guide translates its multi-target profile into assay setup, protocol parameters, comparative applications, and troubleshooting decisions.

• From PLAC1 Biology to Smarter Cancer Screening

  2026-08-18

  A translational framework for moving from PLAC1-associated biology in clear cell renal cell carcinoma to biomarker-aware chemical screening. The article explains how the DiscoveryProbe™ Anti-cancer Compound Library (SKU: L1023) can support mechanism-focused hit discovery, orthogonal validation, pathway mapping, and more disciplined decisions about preclinical relevance.

• Lysosomal β-Galactosidase Staining in HNSCC

  2026-08-17

  Learn how the Lysosomal β-Galactosidase Staining Kit can strengthen senescence interpretation in HNSCC cisplatin-resistance studies. This guide connects lysosomal enzyme imaging with the SLC25A1–H3K27ac mechanism while clarifying controls, assay limits, and practical workflow decisions.

• Prestained Protein Marker for LARP1 Workflows

  2026-08-17

  Build clearer LARP1 ribosome-fractionation and immunoblot workflows with a triple-color, EDTA-free ladder spanning low- and high-molecular-weight targets. The marker combines real-time gel tracking, transfer verification, and compatibility with Phosbind and fluorescent membrane imaging in one practical standard.

• Sodium Ascorbate: ROS Strategy for Translational Oncology

  2026-08-16

  Sodium Ascorbate is a mineral salt of ascorbic acid that can serve as a defined redox perturbation in cancer models. This thought-leadership analysis connects its ROS-driven tumor-cell effects with emerging biomarker frameworks for immunotherapy response, while separating established evidence from exploratory translational hypotheses.

• CAF–ANGPTL4–IQGAP1 Axis in Prostate Cancer

  2026-08-15

  This study identifies a paracrine ANGPTL4–IQGAP1 pathway through which cancer-associated fibroblasts enhance mitochondrial biogenesis, oxidative phosphorylation, and chemotherapy resistance in prostate cancer. Its integrated proteomic, metabolomic, interaction, and pharmacologic evidence supports IQGAP1 and CAF-derived signaling as potential research targets for improving docetaxel responsiveness.

• Coronavirus Macrodomain Counters PARP Antiviral Immunity

  2026-08-14

  Grunewald et al. showed that coronavirus macrodomains protect viral replication by countering host PARP-dependent ADP-ribosylation. Pharmacologic inhibition and selective depletion of PARP12 and PARP14 exposed a virus–host interaction in which PARP activity restricts macrodomain-defective coronavirus and supports interferon production.

• Thrombin B Chain Fragment: Assay Workflows

  2026-08-14

  Use the sequence-defined Thrombin B Chain Fragment as an analytical, binding, and specificity control—not as a substitute for catalytically complete thrombin. This guide translates rigorous protease-screening principles into practical workflows for coagulation, platelet, vascular, and orthogonal assay development.

7955 records 4/531 page Previous Next 12345 下5页 Last page